Cathie Wood's Picks for AI Investment Stocks in 2026

Artificial intelligence continues to reshape global markets, making Cathie Wood AI stock investment strategies a popular topic among investors. Her latest purchases reveal where Ark Invest sees long term opportunities despite recent market volatility.

Rather than chasing short term momentum, Wood focuses on companies developing technologies that could benefit from the growing adoption of AI. Her recent moves span cloud computing, healthcare, digital infrastructure, and advanced technology.

Key Takeaways

• Cathie Wood continues buying AI related companies despite market pullbacks.
• CoreWeave, Meta, Recursion Pharmaceuticals, and SpaceX are among Ark Invest's latest AI focused investments.
• These stocks offer significant growth potential but also carry higher than average investment risk.

What AI Stocks Has Cathie Wood Bought Recently?

Cathie Wood has recently increased Ark Invest's exposure to several companies positioned to benefit from artificial intelligence.

Although these businesses operate in different industries, they all support the expanding AI ecosystem through infrastructure, software, healthcare, or advanced technology.

CoreWeave

CoreWeave has become one of Ark Invest's most notable recent purchases.

The company specialises in AI cloud infrastructure, providing high performance computing power for businesses building and running artificial intelligence models.

Demand continues to rise rapidly.

CoreWeave reported first quarter revenue growth of 114% year over year, while its customer backlog approached $100 billion, reflecting strong long term demand.

Ark Innovation ETF now owns roughly 1.6 million shares, making CoreWeave one of its larger holdings.

Despite that confidence, the stock has experienced significant volatility after falling more than 20% within a few weeks.

Investors remain concerned about the company's rapidly growing debt and substantial infrastructure spending.

CoreWeave at a Glance

Meta

Cathie Wood also added shares of Meta as the company expanded its artificial intelligence strategy.

Meta continues investing heavily in AI models, coding assistants, and computing infrastructure while looking for new ways to generate revenue from these technologies.

Although AI spending remains high, Wood appears to believe these investments can strengthen Meta's long term competitive position.

Recursion Pharmaceuticals

Healthcare is another area where AI is creating new investment opportunities.

Recursion Pharmaceuticals combines artificial intelligence, robotics, and computer vision to analyse millions of biological experiments and identify potential drug candidates more efficiently.

The company currently has several drugs progressing through clinical trials.

It also collaborates with major healthcare companies, including Bayer and Roche, while maintaining a technology partnership with Nvidia.

SpaceX

SpaceX is another company attracting Ark Invest's attention.

Beyond reusable rockets and Starlink, the company continues investing in AI infrastructure, satellite connectivity, and advanced computing technologies.

Recent discussions surrounding future orbital data centres have also increased investor interest.

Although profitability remains under pressure, Wood appears willing to focus on the company's long term technology ambitions rather than near term earnings.

Read Also: How to Invest in AI? Pattern and Strategies

Why Is Cathie Wood Bullish on These AI Stocks?

Cathie Wood invests in companies she believes can benefit from long term technological change rather than short term market trends.

Artificial intelligence remains one of Ark Invest's strongest investment themes because it has the potential to improve productivity across multiple industries.

Rather than buying every company associated with AI, Wood tends to focus on businesses building the technology behind the AI revolution.

AI Infrastructure Remains a Key Theme

One of Wood's biggest convictions is AI infrastructure.

Companies need enormous computing power to train and operate large AI models, creating strong demand for cloud providers and data centre operators.

CoreWeave is a clear example.

Its business focuses on renting high performance computing resources to enterprises developing AI applications, making it an important part of the growing AI ecosystem.

Although infrastructure spending is expensive, Wood appears to believe demand will continue outpacing supply over the coming years.

AI Could Unlock New Revenue for Big Tech

Wood also sees significant opportunities in established technology companies.

Meta is investing billions of dollars into AI models, developer tools, and intelligent assistants designed to improve user experiences and support business customers.

The company is also exploring ways to monetise AI through enterprise services and advertising.

If these initiatives succeed, AI could become another major growth engine alongside Meta's existing digital platforms.

AI Is Changing Healthcare

Healthcare is another sector where AI could create long term value.

Recursion Pharmaceuticals uses machine learning and laboratory automation to analyse millions of biological samples that would take researchers years to study manually.

This approach could accelerate drug discovery while reducing research costs.

However, clinical development remains unpredictable, meaning commercial success is far from guaranteed.

Space Technology Is Becoming More Intelligent

SpaceX represents a different type of AI investment.

Its ambitions extend beyond reusable rockets to include satellite communications, advanced computing, and AI powered infrastructure.

Projects such as Starlink already rely on sophisticated software and automation.

Future investments in computing capacity could further strengthen the company's technology ecosystem if execution matches expectations.

Why These Companies Stand Out

Although these businesses operate in different industries, they share several characteristics.

Wood's investment decisions suggest she prefers companies building the foundations of artificial intelligence rather than simply adding AI features to existing products.

Read Also: Is Demis Hassabis Right? Possibilities of AI Replacing Doctors

Should You Follow Cathie Wood's AI Stock Strategy?

Cathie Wood's portfolio offers valuable investment ideas, but her strategy is designed for investors who can tolerate considerable volatility.

Many of her holdings prioritise future growth over current profitability.

That approach can deliver impressive returns during strong markets.

It can also lead to sharp losses when investor sentiment changes.

CoreWeave highlights both sides of this strategy.

The company is growing rapidly, yet it continues spending heavily on infrastructure while carrying substantial debt.

Recursion Pharmaceuticals faces a different challenge.

Its long term value depends on successfully turning experimental treatments into approved medicines, a process that can take many years.

Meta appears more financially stable.

However, investors still need to determine whether its enormous AI investments will generate enough future revenue to justify the spending.

SpaceX also remains an ambitious long term investment.

Its leadership in satellite internet and space technology creates significant opportunities, but the company's valuation already reflects high expectations.

Is This Strategy Right for You?

Before following Cathie Wood's investment decisions, consider your own goals.

Following a successful investor can provide useful ideas.

However, every investment should be evaluated on its own fundamentals rather than copied simply because a well known fund manager bought the stock.

Diversification also remains essential.

Even innovative companies can underperform if growth slows, competition increases, or market conditions change.

Read Also: Four Investment Areas to Watch for 2026

Conclusion

Cathie Wood continues backing companies she believes are well positioned to benefit from the growth of artificial intelligence. Her recent investments in CoreWeave, Meta, Recursion Pharmaceuticals, and SpaceX highlight Ark Invest's long term focus on AI innovation.

While these stocks offer strong growth potential, they also carry higher risks, including rich valuations and ongoing losses. Always research carefully before investing, and if you're also exploring digital assets, Bitrue provides access to a wide range of cryptocurrencies.

FAQ

What AI stocks has Cathie Wood bought recently?

Cathie Wood has recently added shares of CoreWeave, Meta, Recursion Pharmaceuticals, and SpaceX across several Ark Invest exchange traded funds.

Why is Cathie Wood investing in AI stocks?

Wood believes artificial intelligence can improve productivity across industries, creating long term opportunities in cloud computing, healthcare, software, and digital infrastructure.

Is CoreWeave a good AI investment?

CoreWeave has reported rapid revenue growth and strong customer demand. However, investors should also consider its high debt levels, heavy capital spending, and lack of consistent profitability.

Does Cathie Wood own Meta stock?

Yes. Ark Invest recently increased its position in Meta, reflecting confidence in the company's long term AI strategy and expanding investment in artificial intelligence technologies.

Should investors copy Cathie Wood's portfolio?

Not necessarily. While her investments may provide useful ideas, every investor has different financial goals, risk tolerance, and investment horizons. Independent research remains essential before making any investment decision.

Disclaimer: The views expressed belong exclusively to the author and do not reflect the views of this platform. This platform and its affiliates disclaim any responsibility for the accuracy or suitability of the information provided. It is for informational purposes only and not intended as financial or investment advice.